Abvacc, Inc.
Publicly observedRockville, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Rockville | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Abvacc, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | K5MSGRFGVVZ9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant26 Feb 2024Publicly observed
NIH SBIR/STTR award: Development of a Marburgvirus subunit vaccineadjuvanted with a novel TLR7/TLR8 agonist
USD 297,099.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant11 Aug 2023Publicly observed
NIH SBIR/STTR award: Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant11 Aug 2023Publicly observed
NIH SBIR/STTR award: Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant12 May 2023Publicly observed
NIH SBIR/STTR award: Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
USD 914,818.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.